Mankind Pharma IPO KPI Information
The Mankind Pharma IPO is a book build issue with a total issue size of ₹4326.36 cr, and a offer for sale of 40058844 equity shares. Mankind Pharma IPO opened for subscription on Apr 25, 2023 and closed on Apr 27, 2023. Mankind Pharma IPO is set price band at ₹1026 to ₹1080 per share, with a lot size of 13 shares. Minimum investment for Retail investors was ₹14,040.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on May 03, 2023, and listed on both the NSE and BSE on May 09, 2023.
Kfin Technologies Limited has been appointed as the registrar. IIFL Capital Services Limited, Axis Capital Limited, Jefferies India Private Limited and J.P. Morgan India Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Mankind Pharma IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Mankind Pharma Limited KPI Information
| Particular | The market capitalization of Mankind Pharma IPO is Rs 43263.6 Cr. |
|---|---|
| ROE % | 27.6 |
| ROCE % | 26.1 |
| Debt / Equity | 0 |
| RoNW % | 27.7 |
| PbW | 0 |
| Pat Margin % | 0 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Mankind Pharma IPO is a Book-building IPO with a total issue size of ₹4326.36 crore. The Mankind Pharma IPO price band is ₹1026 to 1080 per share. The Mankind Pharma IPO subscription opens on Tue, Apr 25, 2023, and closes on Thu, Apr 27, 2023. The Mankind Pharma IPO will be listed on the NSE,BSE. Kfin Technologies Limited is the registrar for the Mankind Pharma IPO.
The Mankind Pharma IPO opens on Tue, Apr 25, 2023 and closes on Thu, Apr 27, 2023
Mankind Pharma IPO Price Band is ₹1026 to 1080 per share.
Mankind Pharma IPO lot size is 13 shares, Retail investors need a minimum investment of ₹14040 based on the upper price band
The minimum investment for Mankind Pharma IPO is ₹14040, based on one lot of 13 shares at the upper price band of ₹1080 per share.
Investors can apply for the Mankind Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Apr 27, 2023. The application amount remains blocked until the Mankind Pharma IPO allotment is finalized.
Mankind Pharma IPO issue size is ₹4326.36 crores.
Mankind Pharma IPO allotment date is Wed, Jul 1, 2026.
The registrar for Mankind Pharma IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Mankind Pharma IPO allotment status, refund processing, and other IPO-related information.
The Mankind Pharma IPO GMP (Grey Market Premium) is ₹121 as of Tue, May 9, 2023. Based on the upper price band of ₹1080 per share, the estimated Mankind Pharma IPO listing price is ₹1201, indicating a potential listing gain of approximately 0% over the issue price.